참고문헌
- Sayah, A. English JC 3rd, Rheumatoid arthritis, a review of the cutaneous manifestations, J Am Acad Dermatol, Aug; 53(2):191-209, 2005 https://doi.org/10.1016/j.jaad.2004.07.023
- Setty, A.R., Sigal, L.H. Herbal medications commonly used in the practice of rheumatology; mechanisms of action efficacy and side effects, Semin Arthritis Rheum, 34(6):773-784, 2005 https://doi.org/10.1016/j.semarthrit.2005.01.011
- D.M. Lee, and M.E. Weinblatt, Rheumatoid arthritis, Lancet, 358:903-911, 2001 https://doi.org/10.1016/S0140-6736(01)06075-5
- Aho, K., Koskenvuo, M., Tuominen, J., Kaprio, J. Occurrence of rheumatoid arthritis in a nationwide series of twins, J Rheumatol, 13(5):899-902, 1986
- Aho, K., Palosuo, T., Raunio, V., Puska, P., Aromaa, A., Salonen, J.T. When does rheumatoid disease start, Arthritis Rheum, 28:485-489, 1985 https://doi.org/10.1002/art.1780280503
- Nouri, A.M., Panayi, G.S., Goodman, S.M. Cytokines and the chronic inflammation of rheumatic disease I, The presence of interleukin-1 in synovial fluids, Clin Exp Immunol, 55:295-302, 1984
- Di, Giovine, F.S., Nuki, G., Duff, G.W. Tumour necrosis factor in synovial exudates, Ann Rheum Dis, 47:768-772, 1988 https://doi.org/10.1136/ard.47.9.768
- Nouri, A.M., Panayi, G.S., Goodman, S.M. Cytokines and the chronic inflammation of rheumatic disease I, The presence of interleukin-1 in synovial fluids, Clin Exp Immunol, 55:295-302, 1984
- Blaschke, S., Middel, P., Dorner, B.G., Blaschke, V., Hummel, K.M. and Kroczek, R.A., Reich, K., Benoehr, P., Koziolek, M., Muller, G.A. Expression of activation-induced, T cell-derived and chemokine-related cytokine/lymphotactin and its functional role in rheumatoid arthritis, Arthritis Rheum, 48:1858-1872, 2003 https://doi.org/10.1002/art.11171
- Morand, E.F., Bucala, R., Leech, M. Macrophage migration inhibitory factor; an emerging therapeutic target in rheumatoid arthritis, Arthritis Rheum, 48:291-299, 2003 https://doi.org/10.1002/art.10728
- Bradley, K., Scatizzi, J.C., Shamiyeh, E. Retinoblastoma suppression of matrix metalloproteinase-1 but not interleukin-6, though a p-38-dependent pathway in rheumatoid arthritis synovial fibroblasts, Arthritis Rheum, 50:78-87, 2004 https://doi.org/10.1002/art.11482
- Carson, D.A., Pasquali, J.L., Tsoukas, C.D., Fong, S., Slovin, S.F., Lawrance, S.K., Slaughter, L., Vaughan, J.H. Physiology and pathology of rheumatoid factors, Springer Semin Immunopathol, 4:161-179, 1981 https://doi.org/10.1007/BF01857093
- Joe, B., Griffiths, M.M., Remmers, E.F., Wilder, R.L. Animal models of rheumatoid arthritis and related inflammation, Curr Rheumatol Rep, 1(2):139-148, 1999 https://doi.org/10.1007/s11926-999-0011-7
- Nishimoto, N., Yoshizaki, K., Miyasaka, N., Yamamoto, K., Kawai, S., Takeuchi, T., Hashimoto, J., Azuma, J., Kishimoto, T. Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody, Arthritis Rheum, 50:1761-1769, 2004 https://doi.org/10.1002/art.20303
- Sutton, B., Corper, A., Bonagura, V., Taussig, M. The structure and origin of rheumatoid factors [comment], Immunol Today, 21:177-183, 2000 https://doi.org/10.1016/S0167-5699(00)01589-9
- Tuomi, T., Palosuo, T., Aho, K. The distribution of class-specific rheumatoid factors is similar in rheumatoid and pre-illness sera, Scand J Immunol, 24:751-754, 1986 https://doi.org/10.1111/j.1365-3083.1986.tb02196.x